NEXT CLINICAL RESEARCH ORGANISATION LIMITED - LONDON
Company Profile | Company Filings |
Overview
NEXT CLINICAL RESEARCH ORGANISATION LIMITED is a Private Limited Company from LONDON ENGLAND and has the status: Active.
NEXT CLINICAL RESEARCH ORGANISATION LIMITED was incorporated 9 years ago on 02/02/2015 and has the registered number: 09418105. The accounts status is MICRO ENTITY and accounts are next due on 30/09/2024.
NEXT CLINICAL RESEARCH ORGANISATION LIMITED was incorporated 9 years ago on 02/02/2015 and has the registered number: 09418105. The accounts status is MICRO ENTITY and accounts are next due on 30/09/2024.
NEXT CLINICAL RESEARCH ORGANISATION LIMITED - LONDON
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
47 THE RIDGEWAY
LONDON
N11 3LG
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
09/03/2023 | 23/03/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
OLYMPIA SISMANI | Jan 1965 | Greek | Director | 2015-05-14 | CURRENT |
MR ANDREAS MOSCHOS | Aug 1959 | Greek | Director | 2015-02-02 | CURRENT |
MR TERRY DAVID HARVEY | Oct 1964 | British | Director | 2015-05-14 | CURRENT |
MR DENIS CORNEL LONERGAN | Jan 1964 | British | Director | 2015-02-02 UNTIL 2015-05-14 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Mr Andreas Moschos | 2016-04-07 | 8/1959 | London | Significant influence or control |
Olympia Sismani | 2016-04-07 | 1/1965 | Athens | Ownership of shares 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2023-02-11 | 31-12-2022 | £25,470 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2022-03-11 | 31-12-2021 | £136,231 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2021-09-09 | 31-12-2020 | £932 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2020-03-21 | 31-12-2019 | £-22,047 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2019-06-07 | 31-12-2018 | £-89,639 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2018-03-28 | 31-12-2017 | £-63,716 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2017-09-26 | 31-12-2016 | £4,819 Cash £-62,651 equity |
NEXT_CLINICAL_RESEARCH_OR - Accounts | 2016-12-20 | 31-12-2015 | £1,097 Cash £-38,210 equity |